ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 114512 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 114512; 2) Community: the network communities that were significantly associated with the response to NSC 114512; 3) Molecule: the relationships between components within communities and NSC 114512; 4) MDR: the compounds that were significantly associated with the NSC 114512.

NSC Compound Enrichment Correlation
NSC 756323 GW701427A 0.0415729612483928 0.076462299
NSC 761826 (Z)-3-((1-(4-fluoro-3-methoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0415729612483928 0.16284579
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0415729612483931 0.59699297
NSC 130279 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) 0.0430505868034758 0.27369068
NSC 176323 Camptothecin Derivative 0.0430505868034758 -0.024107196
NSC 708857 Null 0.0430505868034758 0.034097732
NSC 102051 Null 0.0430505868034761 -0.068342963
NSC 105132 Deoxycamptothecin 0.0430505868034761 0.11484799
NSC 113423 NSC 113423 0.0430505868034761 -0.0060139423
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.0430505868034764 0.22353491
Total:165  Current:146    [First] [Prev] [Next] [Last]